Found: 39
Select item for more details and to access through your institution.
Corneal toxicity with belantamab mafodotin: Multi‐institutional real‐life experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E451, doi. 10.1002/ajh.26728
- By:
- Publication type:
- Article
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E276, doi. 10.1002/ajh.26580
- By:
- Publication type:
- Article
First‐ versus second‐generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta‐analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 942, doi. 10.1002/ajh.26552
- By:
- Publication type:
- Article
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E195, doi. 10.1002/ajh.26530
- By:
- Publication type:
- Article
Persistent bone marrow minimal residual disease as a "high‐risk" disease feature in multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E341, doi. 10.1002/ajh.26255
- By:
- Publication type:
- Article
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 739, doi. 10.1002/ajh.24756
- By:
- Publication type:
- Article
Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 2, p. 230, doi. 10.1111/ejh.13541
- By:
- Publication type:
- Article
Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma.
- Published in:
- Journal of Bone & Mineral Research, 2017, v. 32, n. 6, p. 1261, doi. 10.1002/jbmr.3111
- By:
- Publication type:
- Article
3195 Genomic Analysis of Primary Plasma Cell Leukemia reveals Complex Cytogenetic Alterations and High Risk Mutational Patterns.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Richter Syndrome and Brain Involvement: Low-Grade Lymphoma Relapsing as Cerebral High-Grade Lymphoma.
- Published in:
- Acta Haematologica, 2012, v. 127, n. 2, p. 93, doi. 10.1159/000334068
- By:
- Publication type:
- Article
Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes.
- Published in:
- Transplant Infectious Disease, 2019, v. 21, n. 2, p. N.PAG, doi. 10.1111/tid.13052
- By:
- Publication type:
- Article
Severe Right-Sided Heart Failure and Pulmonary Hypertension with Carfilzomib Treatment in Multiple Myeloma.
- Published in:
- Heart Views, 2020, v. 21, n. 4, p. 296, doi. 10.4103/HEARTVIEWS.HEARTVIEWS_107_20
- By:
- Publication type:
- Article
Circulating cell free DNA is a biomarker for GEP70 risk score and tumor burden in myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e62, doi. 10.1016/j.clml.2019.09.096
- By:
- Publication type:
- Article
Long-term Analysis Of Multiple Sequential Samples Reveals Patterns Of Progression In Smoldering Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e59, doi. 10.1016/j.clml.2019.09.092
- By:
- Publication type:
- Article
Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01003-z
- By:
- Publication type:
- Article
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00998-9
- By:
- Publication type:
- Article
Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0336-z
- By:
- Publication type:
- Article
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0226-4
- By:
- Publication type:
- Article
A gene signature can predict risk of MGUS progressing to multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01472-y
- By:
- Publication type:
- Article
Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab.
- Published in:
- EJHaem, 2024, v. 5, n. 4, p. 789, doi. 10.1002/jha2.971
- By:
- Publication type:
- Article
B‐cell maturation antigen‐based therapies post‐talquetamab in relapsed or refractory multiple myeloma.
- Published in:
- EJHaem, 2024, v. 5, n. 3, p. 554, doi. 10.1002/jha2.896
- By:
- Publication type:
- Article
Variability of definition of high‐risk multiple myeloma across phase III clinical trials.
- Published in:
- EJHaem, 2023, v. 4, n. 2, p. 454, doi. 10.1002/jha2.675
- By:
- Publication type:
- Article
Metastatic prostate cancer with bone marrow infiltration mimicking multiple myeloma.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Nasopharyngeal amyloidoma with osteolytic lesions leading to diagnosis of systemic light-chain amyloidosis.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 6, p. 812, doi. 10.1002/ccr3.922
- By:
- Publication type:
- Article
Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant.
- Published in:
- Hematology Reports, 2017, v. 9, n. 3, p. 107, doi. 10.4081/hr.2017.7094
- By:
- Publication type:
- Article
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20524-2
- By:
- Publication type:
- Article
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 16, p. 2491, doi. 10.1002/cncr.34895
- By:
- Publication type:
- Article
High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 283, doi. 10.1111/bjh.17670
- By:
- Publication type:
- Article
Mesenchymal stem cells gene signature in high‐risk myeloma bone marrow linked to suppression of distinct IGFBP2‐expressing small adipocytes.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 578, doi. 10.1111/bjh.15669
- By:
- Publication type:
- Article
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32145-y
- By:
- Publication type:
- Article
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00933-y
- By:
- Publication type:
- Article
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-44873-4
- By:
- Publication type:
- Article
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1116, doi. 10.3390/cancers16061116
- By:
- Publication type:
- Article
EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4519, doi. 10.3390/cancers15184519
- By:
- Publication type:
- Article
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4019, doi. 10.3390/cancers13164019
- By:
- Publication type:
- Article
Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor–T Cell Therapy for Hematological Malignant Neoplasms.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 4, p. e228161, doi. 10.1001/jamanetworkopen.2022.8161
- By:
- Publication type:
- Article
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1640, doi. 10.3390/jcm11061640
- By:
- Publication type:
- Article
Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. e2228877, doi. 10.1001/jamanetworkopen.2022.28877
- By:
- Publication type:
- Article